Updates are available Correction dated 2022-04-13
Click to view Correction: https://doi.org/10.1038/s41388-022-02261-6
-
Authors
Hochnadel, Inga
Hoenicke, Lisa http://orcid.org/0000-0003-0613-8337
Petriv, Nataliia
Neubert, Lavinia
Reinhard, Elena
Hirsch, Tatjana
Alfonso, Juan Carlos Lopez
Suo, Huizhen
Longerich, Thomas
Geffers, Robert
Lichtinghagen, Ralf
Guzmán, Carlos Alberto
Wedemeyer, Heiner
Lenzen, Henrike
Manns, Michael Peter
Bruder, Dunja
Yevsa, Tetyana http://orcid.org/0000-0003-0377-9198
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (YE 151/2-1, LO-1676/4-1)
Fritz Thyssen Stiftung (REF.10.16.1.031MN)
Young Academy MHH (TY), HiLFII MHH (TY), Ellen Schmidt Program MHH (TY), Niedersächsische Krebsgesellschaft e.V. (grant to TY).
Deutscher Akademischer Austauschdienst (Project-ID 91736778)
Wilhelm Sander-Stiftung (2013.107.1)
- License Information
-
More Information
Article History
Received: 18 October 2021
Revised: 14 January 2022
Accepted: 28 January 2022
First Online: 16 February 2022
Change Date: 13 April 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41388-022-02261-6
Competing interests
: H.W. is a consultant by Bayer, Eisai, MSD and Roche, H.W. is a clinical trial investigator by Bayer and Roche. The authors declare no competing interests.
